Paragon 28 - FNA Total Company Value-to-Revenue Ratio

Paragon 28, Inc. (FNA) - corporate logo

On GURU.Markets, the EV/Sales multiple reflects market expectations, where expresses the current value of the metric. This trend is driven by the implementation of innovative orthopedic systems and expansion into the outpatient sector, despite geopolitical threats of supply chain disruptions. Meanwhile, effective outsourcing of standard components combined with in-house design minimizes the operational risks of Paragon 28, Inc. (FNA).

Paragon 28, Inc. (FNA) EV/Sales Multiple: for the period 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for Paragon 28 (FNA)

- share price and consensus valuation forecast:
Fundamental company valuation:FNA, Paragon 28 Corp
Flagship merchandise of paragon28.com

To minimize risks during long-term investing, it is essential to evaluate business value excluding debt, which allows the EV/Sales chart to determine the actual premium for every dollar of revenue. In the case of Paragon 28, Inc. (FNA), this model confirms the efficiency of implant supply chain management, where stable growth in business scale coupled with a moderate multiple indicates high operational resilience.

Competitor analysis

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|PODD (Insulet Inc.) - EV/Sales Multiple|Company Value to Revenue Zimmer Biomet Corp (ZBH)|EV/Sales Multiple COO|Company Value to Revenue Align Technology, Inc. ALGN|EV/Sales Multiple GMED (globusmedical.com)|EV/Sales Multiple TransMedics Group, Inc. TMDX|ATEC - Enterprise Value-to-Revenue Ratio|AORT: Enterprise Value-to-Revenue Ratio|ENOV (Enovis Corporation) - Company Value to Revenue|Integra LifeSciences - Business Value to Revenue|ESTA (Establishment Labs Inc) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Beta Bionics, Inc. BBNX|Enterprise Value-to-Revenue Ratio IRADIMED Corp (IRMD)|Embecta Corp. (EMBC) - Enterprise Value-to-Sales Ratio|Tandem Corp - Company Value to Revenue|EV/Sales Multiple AxoGen, Inc. AXGN|SI-BONE Inc - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Orthofix Medical OFIX|Bioventus Global (BVS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume KIDS (OrthoPediatrics Inc.)|Enterprise Value-to-Revenue Ratio treace.com|Company Value to Revenue Strata Critical Medical Inc (SRTA)|EV/Sales Multiple CARL|RXST - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio clearpointneuro.com CLPT|STXS: Company Value to Revenue Ratio|STIM: Company Value to Revenue|sightsciences.com - Enterprise Value-to-Revenue Coefficient|Orchestra BioMed Inc. (OBIO) - Enterprise Value-to-Revenue Ratio|Anika (ANIK) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio InspireMD, Inc.|zhjmedical.com (ZJYL) - Total Company Value-to-Revenue Ratio|Company Value to Revenue VANI (Vivani Medical)|EV/Sales Multiple Xtant Medical Holdings, Inc. (XTNT)|Enterprise Value-to-Revenue Ratio NeuroOne Medical Technologies Corporation NMTC|EV/Sales Multiple Modular Medical MODD|MYO: Company Value to Revenue|Enterprise Value-to-Revenue Multiple Envoy Medical, Inc.|VVOS (Vivos Therapeutics) - Company Value to Revenue|Company Value to Revenue Ratio NVNO|Company Value to Revenue SINT|Company Value to Revenue Tenon Medical (TNON)|Enterprise Value-to-Revenue Ratio ReWalk Robotics Ltd (LFWD)|Total Company Value-to-Revenue Ratio Autonomix|EV/Sales Multiple IVF (invobioscience.com)|bonebiologics.com - Enterprise Value-to-Revenue Ratio|AXNX - Enterprise Value-to-Revenue Ratio|BIOL (BIOLASE) - Company Value to Revenue Ratio|Dynatronics Corporation (DYNT) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio